A new trading day began on Monday, with Immunome Inc (NASDAQ: IMNM) stock price up 3.42% from the previous day of trading, before settling in for the closing price of $8.76. IMNM’s price has ranged from $5.15 to $16.81 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 56.19%. With a float of $76.80 million, this company’s outstanding shares have now reached $86.96 million.
The extent of productivity of a business whose workforce counts for 118 workers is very important to gauge. In terms of profitability, gross margin is 100.0%, operating margin of -1994.3%, and the pretax margin is -1875.21%.
Immunome Inc (IMNM) Insider and Institutional Ownership
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Immunome Inc is 11.73%, while institutional ownership is 82.18%. The most recent insider transaction that took place on Mar 25 ’25, was worth 60,684. In this transaction Director of this company bought 7,800 shares at a rate of $7.78, taking the stock ownership to the 31,415 shares. Before that another transaction happened on Mar 26 ’25, when Company’s President and CEO bought 137,100 for $7.29, making the entire transaction worth $999,459. This insider now owns 806,736 shares in total.
Immunome Inc (IMNM) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 56.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 24.72% during the next five years compared to -38.15% drop over the previous five years of trading.
Immunome Inc (NASDAQ: IMNM) Trading Performance Indicators
Here are Immunome Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 10.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 72.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.19, a number that is poised to hit -0.52 in the next quarter and is forecasted to reach -2.38 in one year’s time.
Technical Analysis of Immunome Inc (IMNM)
The latest stats from [Immunome Inc, IMNM] show that its last 5-days average volume of 0.95 million was inferior to 1.07 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 86.74%. Additionally, its Average True Range was 0.56.
During the past 100 days, Immunome Inc’s (IMNM) raw stochastic average was set at 53.64%, which indicates a significant decrease from 90.11% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.74% in the past 14 days, which was lower than the 77.13% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.73, while its 200-day Moving Average is $10.85. Now, the first resistance to watch is $9.32. This is followed by the second major resistance level at $9.59. The third major resistance level sits at $9.93. If the price goes on to break the first support level at $8.71, it is likely to go to the next support level at $8.37. The third support level lies at $8.10 if the price breaches the second support level.
Immunome Inc (NASDAQ: IMNM) Key Stats
With a market capitalization of 788.33 million, the company has a total of 87,012K Shares Outstanding. Currently, annual sales are 9,040 K while annual income is -292,960 K. The company’s previous quarter sales were 2,930 K while its latest quarter income was -41,640 K.
